The reactions of the ligand precursor 4-benzyloxybenzoylhydrazine (2) with cinnamaldehyde, salicylaldehyde, 2,4-dimethoxybenzaldehyde, 4-N,N dimethylaminobenzaldehyde, 4-methoxybenzaldehyde formed the ligands C 6 H 5 CH 2 OC 6 H 4 CONHN=CHR, where R=C 6 H 5 CH=CH, (3); C 6 H 4 (OH), (4); C 6 H 3 (OCH 3) 2 , (5); C 6 H 4 N(CH 3) 2 , (6); C 6 H 4 (OCH 3), (7), respectively. The ligand precursor 4-benzyloxybenzoylhydrazine (2) was synthesized by the condensation reaction of ethyl-4-benzyloxybenzoate (1) with hydrazine hydrate. Ethyl-4-benzyloxybenzoate (1) was synthesized by the reaction of ethyl-4-hydroxybenzoate and benzyl bromide dissolved in acetone in presence of anhydrous potassium carbonate. By the reactions of the synthesized ligands with cadmium(II) acetate, a series of complexes [(C 6 H 5 CH 2 OC 6 H 4 CONHN=CHR) 2 Cd] were obtained, where R=C 6 H 5 CH=CH, (8); C 6 H 4 (OH), (9); C 6 H 3 (OCH 3) 2 , (10); C 6 H 4 N(CH 3) 2 , (11); C 6 H 4 (OCH 3), (12). The complexes cannot be obtained via a template method. The compounds have been characterized by elemental analysis, conductivity measurements, UV-visible, FT-IR, 1 H NMR spectral studies. The conductivity measurement data revealed that the complexes are non-electrolytic in nature. The UV-visible data of the complexes suggested the tetrahedral geometry of Cd(II) ion. The antibacterial results of the ligands (3-7) exhibited very low or no activity against pathogenic bacteria viz. gram positive (Bacillus anthracis, Staphylococcus aureus, Bacillus megaterium) and gram negative (Shigella flexneri, Escherichia coli, Shigella shiga), whereas their corresponding complexes (8-12) exhibited activity against the aforementioned bacteria but less than the standard drug, kanamycine. This implies that the activity showed by the complexes is solely responsible for the presence of Cadmium (II) ion.